Back to search

Article

Type 1-polarized DC immunotherapeutic contains heterogeneous populations with IL-12p70 production restricted to a rare subset

2026-05-02

Abstract excerpt

<h4>ABSTRACT</h4> Monocyte-derived DC therapies programmed for robust IL-12p70 production have been associated with favorable outcomes in cancer clinical trials. However, clinical responses remain inconsistent even under standardized protocols, and the cellular basis for this variability is unknown. We leveraged single-cell multiomics to characterize two widely used DC platforms, the high-IL-12p70-producing alpha...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
aa379bcf-aee3-5b28-b43e-d5a80de3761b
DOI
10.64898/2026.04.29.721620
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Type 1-polarized DC immunotherapeutic contains heterogeneous populations with IL-12p70 production restricted to a rare subsetDOI 10.64898/2026.04.29.721620
Select a neighboring publication to make it the new centre.